Biotricity, Inc. (BTCY)
OTCMKTS
· Delayed Price · Currency is USD
0.400
+0.030 (8.11%)
Nov 14, 2024, 3:58 PM EST
Biotricity Revenue
Biotricity had revenue of $3.20M in the quarter ending June 30, 2024, with 5.99% growth. This brings the company's revenue in the last twelve months to $12.24M, up 15.47% year-over-year. In the fiscal year ending March 31, 2024, Biotricity had annual revenue of $12.06M with 25.15% growth.
Revenue (ttm)
12.24M
Revenue Growth
+15.47%
P/S Ratio
0.34
Revenue / Employee
222.62K
Employees
55
Market Cap
9.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 12.06M | 2.42M | 25.15% |
| Mar 31, 2023 | 9.64M | 1.99M | 26.00% |
| Mar 31, 2022 | 7.65M | 4.27M | 126.02% |
| Mar 31, 2021 | 3.38M | 1.97M | 138.75% |
| Mar 31, 2020 | 1.42M | 1.02M | 256.03% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Elekta AB (publ) | 1.69B |
| Ryman Healthcare Limited | 411.39M |
| Verano Holdings Corp. | 897.57M |
| Vireo Growth Inc. | 98.04M |
| Medexus Pharmaceuticals Inc. | 104.76M |
Biotricity News
- 1 day ago - Biotricity to Host Second Quarter Fiscal Year 2025 Financial Results and Business Update Call on November 15th - GlobeNewsWire
- 5 weeks ago - Biotricity reaches EBITDA positive on go-forward cash basis - Seeking Alpha
- 6 weeks ago - Biotricity Provides Updated Guidance for Earlier than Expected Path to Profitability due to Growing Revenues and Improving Margins - Accesswire
- 7 weeks ago - Biotricity Announces Inclusion as a Supplier to A Prominent Medical System That Services 21 States - Accesswire
- 2 months ago - Biotricity Kicks off Another Pilot Program with a Major Hospital System that Services over 800K Individuals - Accesswire
- 3 months ago - Biotricity reports Q1 results - Seeking Alpha
- 3 months ago - Biotricity Reports Continued Margin Improvement and Reduced Losses in its First Quarter Fiscal Year 2025 - Accesswire
- 3 months ago - LOBO EV and Nexalin Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire